News | October 24, 2007

Paieon Demonstrated Stent Deployment Detection

October 25, 2007 - Paieon Inc. demonstrated at TCT 2007 the CardiOp-StentOptimizer, a real-time imaging solution designed to provide detection of suboptimal stent deployment or confirm appropriate deployment for cardiovascular procedures.

StentOptimizer performs post deployment analysis for detecting stent underexpansion and incomplete stent apposition. StentOptimizer provides: stent enhancement; automatic edge detection of stent and vessel; immediate post-deployment results - identification of gaps between stent and vessel.

The CardiOp family of software solutions assists of interventionalists starting from the diagnosis phase, through procedure planning and device positioning to post-deployment analysis. CardiOp-Basic is a 3D coronary reconstruction of diagnosis and procedure planning, CardiOp-Guidance is a device navigation and positioning of interventional procedures and StentOptimizer is a post-deployment analysis for optimizing stent deployment.

For more information: www.paieon.com

Related Content

News | Stents

November 9, 2021 — Results from SUGAR trial, a randomized, controlled, multicenter trial conducted exclusively in ...

Home November 09, 2021
Home
News | Stents

June 30, 2021 — Abbott announced its Xience family of drug-eluting coronary stents received U.S. Food and Drug ...

Home June 30, 2021
Home
News | Stents

April, 14, 2021 – Elixir Medical recently announced the first patient was treated in the BIOADAPTOR randomized ...

Home April 14, 2021
Home
News | Stents

April 6, 2021 — Abbott today announced its Xience stent has received CE mark in Europe for shorter duration of dual anti ...

Home April 06, 2021
Home
News | Stents

December 21, 2020 – A proposed ASTM International standard will answer the need for a standardized test method that ...

Home December 21, 2020
Home
News | Stents

November 24, 2020 — One-year results off the PIONEER III study comparing the safety and efficacy of the Supreme HT ...

Home November 24, 2020
Home
Feature | Stents | Dave Fornell, Editor

October 17, 2020 – In a surprise to many, a randomized clinical trial found that drug-eluting stents (DES) with durable ...

Home October 22, 2020
Home
News | Stents

October 22, 2020 – For patients undergoing percutaneous coronary intervention (PCI), treatment with the nanotechnology ...

Home October 22, 2020
Home
News | Stents

October 1, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for new one-month of dual ...

Home October 01, 2020
Home
News | Stents

July 24, 2020 — CeloNova BioSciences Inc. announced it successfully completed enrollment of the COBRA REDUCE randomized ...

Home July 24, 2020
Home
Subscribe Now